Business
Press Release Mar 25 2022
Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 25-Mar-2022 titled Sun Pharma Presents Phase 3 Data for WINLEVI�� (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 25-Mar-2022 titled Sun Pharma Presents Phase 3 Data for WINLEVI�� (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting View Attachment","length":434,"tagName":"div"}]